UKRI offers up to £4M per award (80% FEC) for pre-clinical to early-phase (up to phase 2a) development of medical countermeasures against CBRN threats. Projects must start by October 2027, last up to 30 months, and improve UK domestic preparedness. Invite-only following a successful expression of interest.
- Affiliation requirementbe employed by a UK based eligible research organisation
- Affiliation restrictionIf you are employed by the following organisations you cannot apply as project lead or project co-lead, but can participate as project partners on an application led by an eligible UK organisation: UK businesses UK charity and third sector organisations
- ComponentsResearch grant: £4,000,000/total
- StatusOpen
For citation in correspondence, application logs, or institutional reporting. Scholiad preserves an immutable record of every posting it surfaces.
Is your institution interested in direct verified listings? Learn about Verified Partnership →